rs10778691

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002480.3(PPP1R12A):​c.792+2212C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.359 in 151,602 control chromosomes in the GnomAD database, including 17,082 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.36 ( 17082 hom., cov: 32)

Consequence

PPP1R12A
NM_002480.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.82

Publications

1 publications found
Variant links:
Genes affected
PPP1R12A (HGNC:7618): (protein phosphatase 1 regulatory subunit 12A) Myosin phosphatase target subunit 1, which is also called the myosin-binding subunit of myosin phosphatase, is one of the subunits of myosin phosphatase. Myosin phosphatase regulates the interaction of actin and myosin downstream of the guanosine triphosphatase Rho. The small guanosine triphosphatase Rho is implicated in myosin light chain (MLC) phosphorylation, which results in contraction of smooth muscle and interaction of actin and myosin in nonmuscle cells. The guanosine triphosphate (GTP)-bound, active form of RhoA (GTP.RhoA) specifically interacted with the myosin-binding subunit (MBS) of myosin phosphatase, which regulates the extent of phosphorylation of MLC. Rho-associated kinase (Rho-kinase), which is activated by GTP. RhoA, phosphorylated MBS and consequently inactivated myosin phosphatase. Overexpression of RhoA or activated RhoA in NIH 3T3 cells increased phosphorylation of MBS and MLC. Thus, Rho appears to inhibit myosin phosphatase through the action of Rho-kinase. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2009]
PPP1R12A Gene-Disease associations (from GenCC):
  • genitourinary and/or brain malformation syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.797 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002480.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP1R12A
NM_002480.3
MANE Select
c.792+2212C>A
intron
N/ANP_002471.1
PPP1R12A
NM_001143885.2
c.792+2212C>A
intron
N/ANP_001137357.1
PPP1R12A
NM_001244990.2
c.792+2212C>A
intron
N/ANP_001231919.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP1R12A
ENST00000450142.7
TSL:1 MANE Select
c.792+2212C>A
intron
N/AENSP00000389168.2
PPP1R12A
ENST00000437004.6
TSL:1
c.792+2212C>A
intron
N/AENSP00000416769.2
PPP1R12A
ENST00000550107.5
TSL:1
c.792+2212C>A
intron
N/AENSP00000446855.1

Frequencies

GnomAD3 genomes
AF:
0.359
AC:
54336
AN:
151482
Hom.:
17015
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.804
Gnomad AMI
AF:
0.0548
Gnomad AMR
AF:
0.291
Gnomad ASJ
AF:
0.229
Gnomad EAS
AF:
0.789
Gnomad SAS
AF:
0.450
Gnomad FIN
AF:
0.164
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.107
Gnomad OTH
AF:
0.288
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.359
AC:
54476
AN:
151602
Hom.:
17082
Cov.:
32
AF XY:
0.364
AC XY:
26964
AN XY:
74112
show subpopulations
African (AFR)
AF:
0.804
AC:
33293
AN:
41404
American (AMR)
AF:
0.292
AC:
4442
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.229
AC:
794
AN:
3468
East Asian (EAS)
AF:
0.788
AC:
4060
AN:
5150
South Asian (SAS)
AF:
0.451
AC:
2167
AN:
4810
European-Finnish (FIN)
AF:
0.164
AC:
1709
AN:
10398
Middle Eastern (MID)
AF:
0.228
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
0.107
AC:
7269
AN:
67840
Other (OTH)
AF:
0.297
AC:
625
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1044
2088
3132
4176
5220
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
450
900
1350
1800
2250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.261
Hom.:
1435
Bravo
AF:
0.386
Asia WGS
AF:
0.667
AC:
2297
AN:
3448

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.067
DANN
Benign
0.47
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10778691; hg19: chr12-80219888; API